Multiple Sclerosis International Federation 9 June 2009


website | contact us | donate
{{if listFind(vars.channel_names, "MSIF News")}}
{{endif}}
{{if listFind(vars.channel_names, "MSIF News")}}
{{endif}}
{{if listFind(vars.channel_names, "MSIF News")}}

MSIF News
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}

Profile of the Month
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}

Research News
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}

MS News
{{endif}}
{{if listFind(vars.channel_names, "MSIF News")}}
{{endif}}
{{if listFind(vars.channel_names, "People With MS News")}}
{{endif}}
{{if listFind(vars.channel_names, "Research News")}}
{{endif}}
{{if listFind(vars.channel_names, "MS Society News")}}
{{endif}}
 

Making Connections

 

MSIF News

Summaries of new MSIF activities, events, projects, programmes, resources, publications and more.
MSIF CEO Peer Baneke visits Japan MS Society

Peer Baneke, MSIF CEO, met with Yoshitami Arai, President, and Nagatoshi Aida, Secretary General, of the Japan MS Society whilst in Tokyo, Japan in early June 2009.

read more

   
 

Profile of the Month

Summaries of news, views and achievements from people with MS around the world.
Lori Schneider Everest summit with flag

Profile of the Month : January 2010

Lori Schneider

Country: USA
Age: 52
Type of MS: rapidly progressing
Year of Diagnosis: 1999

"It was an amazing feeling to go step by step by step up Mount Everest with the World MS Day flag in my pack. Each step was hard and I had to concentrate on every aspect, and I had to really convince myself to keep going. It gave me a whole new feeling for people with MS who may have a hard time walking across a room. My difficulty on the mountain was short-lived, but I realised that some people with MS experience this level of difficulty with every step they take. I encourage them not to give up hope and to keep following their dreams!"


العربية Deutsch English Español French Italiano Русский

read more

   
 

Research News

Summaries of all the latest research findings on MS selected by a team based at the Institute of Neurology, London.
Remyelination capacity of the MS brain decreases with disease chronicity

MS is an inflammatory-demyelinating disease of the central nervous system. It is known that demyelinated areas can recover the myelin by an internal repair mechanism of the damaged neural tissue by a process called remyelination. However, little is known about the characteristics of this protective process. The authors of this study aimed to investigate the frequency of remyelination in people with MS with different disease durations and the areas where this protective phenomenon was more prominent. They finally conclude that remyelination was more prominent in earlier stages of the disease and also that the location of the lesion may influence the extent of the remyelination.

authors: Goldschmidt T, Antel J, König FB, Brück W, Kuhlmann T

source: Neurology. 2009 Jun 2;72(22):1914-21

read more

Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study

The aim of this placebo-controlled clinical trial was to investigate the beneficial effects of cladribine given subcutaneously in people with MS compared to placebo. The 84 patients in the study were divided into two groups. One group received cladribine first and a placebo afterwards and the other group received a placebo first and the cladribine afterwards. The results showed that cladribine was effective in people with MS mainly because it provoked a reduction in the relapse rate.

authors: Stelmasiak Z, Solski J, Nowicki J, Jakubowska B, Ryba M, Grieb P

source: Mult Scler. 2009 Jun;15(6):767-70

read more

Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria

Some years ago interferon (IFN) beta was tested in people with a first episode suggestive of MS. It was proven to be effective in delaying the appearance of a second MS relapse. In the current study the authors have re-analysed the data from the former trial and have concluded that IFN beta was especially beneficial in delaying the second attack for those people whose first episode showed involvement of only one anatomical area. This finding reinforces the need for early disease modifying treatment after a first episode suggestive of MS, even when only mild anatomical involvement is observed.

authors: O'Connor P, Kinkel R, Kremenchutzky M

source: Mult Scler. 2009 Jun;15(6):728-34

read more

Twin studies and the heritability of MS: a conclusion

MS is a complex disease in which genes may play a role. In this study the authors aimed to investigate the relative contribution of genes and the environment to the appearance of MS by re-analysing six published studies from six countries, on people with MS who were twins. The authors found that the different methodologies and the huge variability in the results of the different studies prevented them from obtaining robust conclusions. They also suggested that further twin studies with improved methodology should be undertaken in people with MS, to more thoroughly investigate the genetic influence in the appearance of MS.

authors: Hawkes Ch, Macgregor A

source: Mult Scler. 2009 Jun;15(6):661-7

read more

   
 

MS News

Summaries of MS news from websites around the world.
"Tome control de su EM" (Take control of your MS) published by US National MS Society

source: US National MS Society

The US National MS Society has produced a new information kit for Spanish-speaking people living with MS.

read more

"Understanding MS" now available in Finnish

source: Deutsche Multiple Sklerose Gesellschaft Bundesverband

"Understanding MS," an online guide produced by the German MS Society, Deutsche Multiple Sklerose Gesellschaft Bundesverband (DMSG), is now available in three languages including Finnish.

read more

MS Ireland launches booklets about exercise and MS

source: MS Ireland

MS Ireland has launched two new publications "Everybody Stretch" and "MS and Fitness."

read more

Mini marathon for MS to take place in Goiana, Brazil, on 9 August 2009

source: MS Association of Goiana, Brazil

The Associação Goiana de Esclerosis Múltipla, (MS Association of Goiás) is organising a mini marathon to raise MS awareness and funds, in Goiânia, Goiás, Brazil, on 9 August 2009.

read more

 

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.